The ultimate proof to confirm the impact of β-HCH on cancer initiation is the enhanced proliferative activity attested to by the increased expression of Ki67, a prognostic marker associated with clinically advanced tumors, and the higher number of colonies obtained from the clonogenic assay. This evidence concerns the gene MKI67 and cancer.